chr5-177280796-C-T
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_022455.5(NSD1):c.5854C>T(p.Arg1952Trp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_022455.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The R1952W pathogenic variant in the NSD1 gene has been reported previously in association with Sotos syndrome(Tatton-Brown et al., 2005; Saugier-Veber et al., 2007). Functional studies indicate that R1952W impairs the histonelysine methyltransferase activity of the NSD1 enzyme (Qiao et al., 2011). R1952W was not observed inapproximately 6,500 individuals of European and African American ancestry in the NHLBI Exome SequencingProject, indicating it is not a common benign variant in these populations. This substitution occurs at a highlyconserved position that is predicted to be within the SET domain of the NSD1 protein. In silico analysis predicts thisvariant is probably damaging to the protein structure/function. -
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1952 of the NSD1 protein (p.Arg1952Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Sotos syndrome (PMID: 15942875, 17565729, 22924495, 34033256). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 279858). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NSD1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects NSD1 function (PMID: 21196496, 24412544). For these reasons, this variant has been classified as Pathogenic. -
Sotos syndrome Pathogenic:2
- -
- -
NSD1-related disorder Pathogenic:1
The NSD1 c.5854C>T variant is predicted to result in the amino acid substitution p.Arg1952Trp. This variant has been reported in several individuals with suspected Sotos syndrome; in at least one individual, this variant was found to be de novo (Tatton-Brown et al. 2005. PubMed ID: 15942875; Fortin et al. 2021. PubMed ID: 34033256; Pohjola et al. 2012. PubMed ID: 22924495). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at